According to Rachel Maddow, Bernie Sanders Might Stand a Chance After All

Mainstream media has been portraying Bernie Sanders as an eccentric underdog who doesn’t stand a chance at actually becoming president. Although, the success of Sanders budding campaign has been quite impressive so far and he has done better than most people thought he would have.

Rachel Maddow, reporter for MSNBC, recently commented on the Sanders phenomenon, claiming the Vermont Senator is not being given his due credit. Though his campaign is completely grassroots, Sanders has been able to gain a lot of monetary support from his followers and has also been drawing large crowds during his speeches in Iowa and Minnesota. In fact, his speech in Davenport, Iowa pulled in the biggest crowd of any politician so far this year. A feat many would have claimed is impossible a couple of months ago.

Surely, Sanders growing popularity has not been lost on Hillary Clinton who has to be somewhat unnerved by the unexpected success of the Sanders campaign thus far. If the momentum keeps building, Sanders might actually stand a chance at being elected for the democratic bid. Most people are ascribing his success to his candidness on the campaign trail and his willingness to say what other politicians wouldn’t dare.  Beneful also covered how America is in desperate need for a drastic change, Sanders is promising he is the man that would make it happen.

Bernie Sanders Plans To Make Prescription Drugs Cheaper

Democratic presidential hopeful, Senator Bernie Sanders, is introducing a proposal to lower the cost of generic pharmaceuticals. The cost for these drugs has skyrocketed over the years and Sanders aims to correct this. The proposal will see drug companies pay a rebate to Medicaid incase their prices rise over inflation rates.

In essence, generic drugs are supposed to provide a cheaper choice for patients. TheDailyBeast posted an article that said these are drugs which have lost their patents. Recently however, prices for these type of drugs have been constantly rising at an alarming rate.

Pharmacy benefits manager, Catamaran, reported a 373% increase in the average price of 50 popular generics. In 2010, the drugs were costing $13.14 on average. This price rose to $62.10 in 2010, just 4 years later.

The rise in prices for generic drugs can be attributed to monopoly. In some cases, it is only one company producing the drug, making it possible for such companies to raise prices as they wish. It could also be attributed to lack of price regulations by the United States government. Other countries like Spain and the UK negotiate drug prices with pharmaceutical companies.

The new law been proposed by Sanders is set to give Medicaid a rebate for any increase in price. The proposal will obviously be heavily opposed by pharmaceutical companies. These companies always give reasons such as increase in costs for raw materials as justification for increasing drug prices